196 related articles for article (PubMed ID: 35974000)
1. FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma.
Li J; Zhang Y; Wang L; Li M; Yang J; Chen P; Zhu J; Li X; Zeng Z; Li G; Xiong W; McCarthy JB; Xiang B; Yi M
Cell Death Dis; 2022 Aug; 13(8):711. PubMed ID: 35974000
[TBL] [Abstract][Full Text] [Related]
2. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
Zhang M; Wu CH; Zhu XL; Wang YJ
Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
[TBL] [Abstract][Full Text] [Related]
4. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
[TBL] [Abstract][Full Text] [Related]
5. Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.
Min HY; Lee SC; Woo JK; Jung HJ; Park KH; Jeong HM; Hyun SY; Cho J; Lee W; Park JE; Kwon SJ; Lee HJ; Ni X; Shin YK; Johnson FM; Duvic M; Lee HY
Clin Cancer Res; 2017 Mar; 23(5):1299-1311. PubMed ID: 27582487
[No Abstract] [Full Text] [Related]
6. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
7. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
Kondo M; Takahashi T
Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
[TBL] [Abstract][Full Text] [Related]
8. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma.
Kohda M; Hoshiya H; Katoh M; Tanaka I; Masuda R; Takemura T; Fujiwara M; Oshimura M
Mol Carcinog; 2001 Aug; 31(4):184-91. PubMed ID: 11536368
[TBL] [Abstract][Full Text] [Related]
10. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
11. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Hofmann WK; Takeuchi S; Frantzen MA; Hoelzer D; Koeffler HP
Exp Hematol; 2002 Apr; 30(4):318-23. PubMed ID: 11937266
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
16. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
Vu TH; Nguyen AH; Hoffman AR
Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
19. Targeted tumor gene therapy based on loss of IGF2 imprinting.
Pan Y; He B; Li T; Zhu C; Zhang L; Wang B; Xu Y; Qu L; Hoffman AR; Wang S; Hu J
Cancer Biol Ther; 2010 Aug; 10(3):290-8. PubMed ID: 20592487
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.
Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S
Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]